Mesenchymal stem cell-based therapy for non-healing wounds due to chronic limb-threatening ischemia: a review of preclinical and clinical studies

CT Huerta, FA Voza, YY Ortiz, ZJ Liu… - Frontiers in …, 2023 - frontiersin.org
Progressive peripheral arterial disease (PAD) can result in chronic limb-threatening
ischemia (CLTI) characterized by clinical complications including rest pain, gangrene and …

Endovascular and surgical venous arterialization for no-option patients with chronic limb-threatening ischemia: a systematic review and meta-analysis

A Ucci, P Perini, A Freyrie, MA Schreve… - Journal of …, 2023 - journals.sagepub.com
Background: Chronic limb-threatening ischemia (CLTI) is known for its high rates of major
amputation and mortality. Conventional revascularization techniques often fail in CLTI …

[HTML][HTML] Early experience with venous arterialization for limb salvage in no-option patients with chronic limb-threatening ischemia

JA Miranda, Z Pallister, S Sharath, L Ferrer… - Journal of Vascular …, 2022 - Elsevier
Objective Chronic limb-threatening ischemia (CLTI) is associated with adverse limb
outcomes and increased mortality. However, a small subset of the CLTI population will have …

2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS guideline for the management of lower extremity peripheral artery disease: a report of the …

WC Members, HL Gornik, HD Aronow… - Journal of the American …, 2024 - Elsevier
Abstract Aim The “2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS
Guideline for the Management of Lower Extremity Peripheral Artery Disease” provides …

Short and Mid Term Outcomes of Percutaneous Deep Venous Arterialisation for No-option Chronic Limb Threatening Ischaemia: A Systematic Review and Meta …

J Tsukagoshi, M Orrukem, J Shimamura… - European Journal of …, 2024 - Elsevier
Objective Percutaneous deep venous arterialisation (pDVA) is a state of the art technique for
treating patients with chronic limb threatening ischaemia (CLTI) with no conventional option …

[PDF][PDF] CLINICAL PRACTICE GUIDELINES

L Byrd, V Chandra, DE Drachman, JM Eaves… - Circulation, 2024 - portailvasculaire.fr
AIM: The “2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline
for the Management of Lower Extremity Peripheral Artery Disease” provides …

Management of the no-option foot: Deep vein arterialization

S Ilyas, RJ Powell - Seminars in Vascular Surgery, 2022 - Elsevier
The incidence of peripheral artery disease continues to rise worldwide, with a concomitant
rise in the subset of patients who manifest with chronic limb-threatening ischemia (CLTI). A …

Adipose derived stromal vascular fraction and mesenchymal stem cells improve angiogenesis in a rat hindlimb ischaemia model

HM Hahn, YN Youn, JS Lee, IJ Lee, SH Lim - European Journal of …, 2024 - Elsevier
Objective This study aimed to investigate the effect of human adipose tissue derived stromal
vascular fraction (AD-SVF) and mesenchymal stem cells (AD-MSCs) on blood flow recovery …

A review of percutaneous deep vein arterialization for the treatment of nonreconstructable chronic limb threatening ischemia

D Clair, M Gibbons - Seminars in Vascular Surgery, 2021 - Elsevier
Peripheral arterial disease is estimated to affect more than 200 million people worldwide
with some patients progressing to chronic limb threatening ischemia (CLTI). Patients with …

Comparison of clinical outcomes, including the wound healing rate, between inframalleolar bypass to the pedal artery and that to the pedal branch artery in the …

A Kodama, T Kobayashi, A Guntani, T Yamada… - Journal of Vascular …, 2022 - Elsevier
Objective Inframalleolar (IM) bypass has been reported to demonstrate acceptable patency
and limb salvage in patients with chronic limb-threatening ischemia. However, wound …